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Objectives. This study sought o evaluate, in a prospective and 
randomized trial, the relative eflicacies of three possible thera- 
peutic strategies for patients with a single severe proximal steno- 
sis of the left anterior descending coronary artery and stable 
angina. 
Background. Although percutaneous transluminal coronary 
angioplasty and coronary artery bypass surgery are often per- 
formed in patients with a single proximal stenosis of the left 
anterior descending coronary artery, it is unclear whether evas- 
cularization offers greater clinical benefit han medical therapy 
alone. 
Methods. At a single center, 214 patients with stable angina, 
normal ventricular function and a proximal stenosis of the left 
anterior descending coronary artery >80% were randomly as- 
signed to undergo mammary bypass surgery (n = 70), balloon 
angioplasty (n = 72) or medical therapy alone (n = 72). Angio- 
plasty had to be considered technically feasible in every case. The 
predefined primary study end point was the combined incidence of 
cardiac death, myocardial infarction or refractory angina requir- 
ing revascularization. 
Results. At an average follow-up eriod of 3 years, a primary 
end point had occurred in only 2 patients (3%) assigned to bypass 
surgery compared with 17 assigned to angioplasty (24%) and 12 
assigned to medical therapy 117%) (p = 0.0002, angioplasty vs. 
bypass urgery; p = 0.006, bypass urgery vs. medical treatment; 
p = 0.28, angioplasty vs. medical treatment, all by log-rank test). 
There was no difference inmortality or infarction rates among the 
groups. However, no patient allocated to bypass urgery needed 
revascularization, compared with eight and seven patients as- 
signed, respectively, to coronary angioplasty and medical treat- 
ment (p = 0.019). Both revascularization techniques resulted in 
greater symptomatic relief and a lower incidence of ischemia on 
the treadmill test; however, all three strategies eventually resulted 
in the abolition of limiting angina. 
Conclusions. The more aggressive therapeutic approach with 
initial bypass urgery for patients with a single severe proximal 
stenosis of the left anterior descending coronary artery is associ- 
ated with a lower incidence of medium-term adverse vents than 
coronary angioplasty or medical treatment. However, all three 
strategies resulted in a similar incidence of death and infarction 
during an average follow.up period of 3 years. This information 
should be taken into consideration when physicians and patients 
make therapeutic choices in this setting. 
(J Am CoU Cardiol 1995;26:1600-5) 
Although prior studies 11,2) have demonstrated nodifference 
in survival or myocardial infarction rates in patients with 
single-vessel disease who undergo revascularization proce- 
dures or receive medical therapy, these patients represent a 
heterogeneous group. This heterogeneity is particularly true 
for patients with stenosis of the left anterior descending 
coronary artery because the extent of myocardium at risk 
varies, depending in part on the amount of territory supplied 
by the vessel and in part on the location of the stenosis (3). 
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Indeed, patients with proximal lesions before the first septal 
perforator have a significantly worse prognosis than those with 
distal disease in the same vessel (4). 
Most of the information concerning the comparative use- 
fulness of medical and surgical therapy in patients with stable 
angina is derived from the classic randomized studies per- 
formed in the 1970s. However, both medical therapy and 
surgical techniques have evolved significantly since then. One 
such example in the surgical field is the increasing use of the 
internal mammary artery grafts, now recognized for their 
association with improved long-term survival and freedom 
from cardiac events compared with that for saphenous vein 
grafts (5). Medical therapy has also evolved, with increased 
recognition of the benefits of antiplatelet, hrombolytic and 
beta-adrenergic blocking agents and angiotensin-converting 
enzyme inhibitors (6-8). Another factor is the frequent use of 
percutaneous transluminal coronary angioplasty. Coronary an- 
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gioplasty was initially described after completion of enrollment 
in the large randomized trials of surgical and medical therapy 
in patients with stable angina. However, despite the wide- 
spread use of this procedure, its specific role vis-a-vis medical 
and surgical therapy remains to be established. Although 
several ongoing randomized trials comparing surgical revascu- 
larization and angioplasty are underway, none has a medical 
treatment arm (9-15). 
Specifically, there are no relevant up-to-date data compar- 
ing medical, surgical and angioplasty therapies for patients 
with proximal left anterior descending coronary artery disease. 
The purpose of the present study was to evaluate whether 
coronary angioplasty or bypass urgery offers any advantage 
over medical therapy in patients with stable angina, normal eft 
ventricular function and a single severe proximal stenosis of 
the left anterior descending coronary artery. 
Methods 
Study patients. To increase the homogeneity of the three 
treatment groups, only patients creened and treated at a 
single institution, the Heart Institute of the University of Silo 
Paulo, were included in the study. In addition, the surgeon and 
the interventional cardiologist who participated in the trial had 
considerable xperience, defined as the performance of 
>10,000 procedures each. These two investigators were the 
sole operators of revascularization procedures in the present 
trial. Medical care and follow-up was provided by a senior staff" 
cardiologist with > 15 years of experience in treating coronary 
artery disease. Patients with unstable angina, prior infarction, 
significant valvular disease, cardiomyopathy, left ventricular 
dysfunction, a previous coronaw inte~'ention or prior open 
heart surgery were exchlded. Patients from other states or 
those unable to make regular hospital visits were also excluded. 
Written informed consent was obtained from all patients. Both 
the consent form and the study protocol were approved by our 
institute's committee on ethics and human research. 
From 1988 to 1991, we enrolled 214 patients with stable 
angina and single-vessel disease with at least 8()~)~ diameter 
stenosis in the left anterior descending coronary artery before 
the first diagonal branch. Angiographic exclusion criteria were 
total occlusion, lesion length >12 mm, involvement of the 
ostium, heavy calcification, severe tortuosity and stenosis of the 
left main coronary artery. The left anterior descending coro- 
nary artery lesion was above the first septal perforator in 89C,2 
of the patients on average, and the three treatment groups 
were similar with respect o lesion locatkm. All cine films were 
reviewed by a cardiac surgeon, an interventional cardiologist 
and the attending physician. Either revascularization strategy 
had to be considered technically feasible by the consensus of 
the three investigators before randomization. 
If the treatment failed, patients could be withdrawn from 
the protocol by their attending physician and assigned to a 
different treatment. If refractory angina occurred, patients 
assigned to medical therapy underwent angioplasty or bypass 
surgery. Patients initially allocated to angioplasty usually un- 
derwent surgical revascularization, and those who underwent 
initial surgical revascularization also underwent angioplasty. 
Repeat angioplasty in the event of restenosis was permitted as 
an integral part of the angioplasty strategy, and the procedure 
was repeated as many times as deemed necessary by the 
attending physician and interventional cardiologist. The max- 
imal number of repeat procedures was four, and the average 
number of angioplasty procedures/patient was1.6. 
Twenty percent of the patients creened refused to partic- 
ipate in the trial; 5% were participants in other trials; 5% had 
unstable angina; 6% had previously undergone angioplasty; 
2% had heart failure; 28% had lesions considered not suitable 
for coronary angioplasty; 19% had lesions <70% diameter 
stenosis, 8% had multivessel disease; and 10% had a left 
anterior descending coronary artery lesion involving the first 
diagonal branch and were excluded by mutual agreement of
the investigators. In some patients, the presence of more than 
one factor led to their exclusion from the trial. 
Medical therapy. Patients allocated to medical therapy 
alone received treatment according to a predefined approach 
that included aspirin, nitrates, beta-blockers and calcium chan- 
nel blocking agents, unless contraindicated, to eliminate symp- 
toms of angina. 
Balloon angioplasty. Balloon angioplasty was performed 
according to standard protocols that included aspirin and, for 
most patients, nifedipine before the procedure. Intravenous 
heparin (1(I,000 U) and nitroglycerin were infused uring the 
procedure. ('oronary angiograms were repeated at 6 months or 
sooner if symptoms of angina recurred. Angioplasty was re- 
pealed if significant restenosis occurred. In the event of abrupt 
closure of the dilated artery, the interventional cardiologist 
and attending physician were allowed to decide whether to 
refer the patient for emergency b pass urgery. 
Surgical revascularization. All patients assigned to surgi- 
cal revascularization u derwent bypass grafting using the left 
internal mammary artery. Extracorporeal circulation was used 
for all patients, and the perfusion rate was maintained at2.0 to 
2.4 liters/m z per min under mild hypothermia (34 to 35°C). The 
anastomoses were performed uring a short period of cardiac 
arrest after aortic cross-clamping. Distal anastomoses were 
performed under optical magnification. 
Follow-up. After discharge, all patients were seen and 
examined every 3 mo at the Heart Institute. Unless contrain- 
dicated, all patients received aspirin, nitrates and beta- and 
calcium channel blockers. Patients underwent a symptom- 
limited treadmill exercise test at baseline and after 2 years of 
randomization according to a modified Bruce protocol, unless 
contraindicated. Coronary angiography was repeated in all 
patients after 2 years. Patients assigned to coronary angioplasty 
underwent routine coronary angiography also at 6 months. 
Study end points. The predefined primary study end point 
was the combined incidence of cardiac death, myocardial 
infarction or refractory angina requiring revascularization. 
Surgical revascularization, but not repeat coronary angioplasty, 
was considered an end point for patients assigned to coronary 
angioplasty. Secondary outcomes were angina functional class 
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at the last follow-up visit, employment s atus and positive 
exercise test results 2 years after enrollment and degree of 
atherosclerotic nvolvement of the coronary arteries at the 
2-year angiographic study. 
Symptoms of angina were graded according to severity, 
from 1 to 4, as previously defined (16). Refractory angina 
was considered only when patients had been treated with 
anti-ischemic therapies (usually triple-drug therapy) to their 
tolerance level. Myocardial infarction was defined by the 
development of significant new Q waves in at least two 
electrocardiographic leads or when symptoms were compatible 
with a myocardial infarction associated with elevation of the 
creatine kinase, MB fraction to greater than three times the 
upper limit of normal. 
Ventricular function. Patients underwent contrast left ven- 
triculography during the baseline and follow-up cardiac cath- 
eterizations in the right anterior oblique projection. The 
endocardial contours were traced uring systole and diastole of 
a normal sinus beat, and the global left ventricular ejection 
fraction was obtained using the area-length method, as previ- 
ously described (17). 
Statistical analysis. Data are reported as mean value ± 
SD. Discrete variables in the groups were compared by the 
Fisher exact and chi-square tests, and continuous variables 
were compared using analysis of variance. The event-free 
probabilities in the groups were estimated by the Kaplan- 
Meier method and compared by the log-rank test. All analyses 
were performed according to intention to treat, and the 
reported statistics are two-tailed: p < (t.05 was considered 
significant. 
Resu l ts  
Patients. Two hundred fourteen patients met all entry 
criteria and were randomized to undergo bypass urgery (70 
patients), balloon angioplasty (72 patients) and medical treat- 
ment alone (72 patients). The three groups did not differ with 
respect o baseline clinical, angiographic and laboratory char- 
acteristics, as shown in Table 1. The average follow-up period 
was 3.5 ± 1.5 years. 
Primary end points. Medical therapy. In the medical ther- 
apy group, two patients ustained an uncomplicated myocar- 
dial infarction, four were referred for bypass urgery, and three 
were referred for angioplasty because of refractory angina. 
There were no deaths or strokes. 
Bypass urgery. Of the 7(I patients assigned to left internal 
mammary artery bypass urgery, one patient had a periopcra- 
tive infarction, and one died on the way to the hospital after 
the onset of chest pain 43 mo after bypass urgery. No patient 
required angioplasty and there were no strokes. 
Coronary angioplasty. Angioplasb' was clinically successful 
in 96% of the 72 patients initially assigned to coronary 
angioplasty. It was not possible to dilate the stenosis in three 
patients, two of whom had a periprocedural myocardial infarc- 
tion and were referred for emergent bypass urgery. During 
the follow-up period, 27 patients assigned to this group 
Table 1. Baseline Characteristics of 214 Study Patients 
Medical Mammary 
Therapy PTCA Bypass 
(n = 72) (n = 72) (n = 70) 
Clinical 
Age (yr) 58 _+ 7 54 - 9 58 -+ 11 
Male gender (no.) 59 58 58 
Hypertension (%) 38 34 30 
Diabetes (%) 20 15 18 
Current smoker (%) 36 36 37 
Employed (%) 89 88 90 
Laboratory values (mg/dl) 
Total cholesterol 240 _+ 40 213 _+ 49 230 _+ 45 
LDL cholesterol 162 _+ 36 141 -- 42 155 -- 36 
HDL cholesterol 41 + 9 38 _+ 9 37 -- 8 
Triglycerides 199 _+ 111 192 _+ 126 220 _+ 110 
Positive TI-201 stress 86 82 84 
scintigraphic results (%) 
Angiographic findings 
Mean stenosis (%) 89 86 88 
Ejection fraction (%) 74 + 4 77 + 6 74 _+ 4 
Unless otherwise indicated, data presented are mean value +_. SD. HDL - 
high density lipoprotein: LDL = low density lipoprotein; PTCA = percutaneous 
transluminal coronary angioplasty; TI = thallium. 
(37.5%) had repeat angiography because of refractory angina, 
and 21 underwent one or more additional angioplasty proce- 
dures. Eight patients had refractory angina requiring elective 
bypass surgery. No patient was referred to bypass surgery 
solely as a result of 6-month follow-up angiography. One 
patient assigned to angioplasty died suddenly at home 8 
months after the procedure. There were no strokes. 
The event-free probability at an average follow-up period of 
3 years in the patients initially allocated to bypass urgery was 
97%, significantly greater than that for those assigned to the 
other two groups and did not differ between those randomized 
to coronary angioplasty (76%) and those randomized tomed- 
ical therapy (83%) (p = 0.0002 for coronary angioplasty vs. 
bypass surgery; p = 0.006 for bypass surgery vs. medical 
treatment, log-rank test) (Fig. 1). 
Angina. There was a marked suppression of angina in 
patients randomized to both revascularization strategies: 68 
patients assigned to bypass urgery (98%) and 58 randomized 
to coronary angioplasty (82%) were totally asymptomatic at
the last follow-up visit an average of 3 years after enrollment. 
In contrast, only 23 patients randomized tomedical treatment 
(32%) were asymptomatic at the 3-year follow-up visit (p < 
0.01 for bypass urgery vs. coronary angioplasty; p < 0.01 for 
coronary angioplasty vs. medical treatment). No patient in any 
randomized group had limiting angina (functional c ass III or 
IV) at the last follow-up visit. 
Treadmill test. One hundred sixty-five patients underwent 
exercise treadmill tests after 2 years of follow-up. Ninety-four 
percent of those randomized to bypass urgery, 79% of those 
to assigned coronary angioplasty and 34% of those assigned to 
medical therapy were ischemia free on this stress test (p < 0.01 
for medical therapy vs. both revascularization strategies). 
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Figure 1. Event-free probability for the three treatment groups during 
the follow-up period. Note that the patients assigned to bypass urge U 
had a lower incidence of events during follow-up (Kaplan-Meier 
analysis; see Methods for definition of events). Numbers below the 
graph are number of patients reaching each time point in each group. 
Employment status. There was no difference among the 
groups with respect o the proportion of patients regularly 
working 2 years after randomization. Fifty-six of the patients 
assigned to medical treatment (78%), 46 of those randomized 
to coronary' angioplasty (64cA) and 56 of those who initially 
underwent bypass urgery (80%) were employed (p = NS). 
Angiography. All patients agreed to undergo repeat an- 
giography after 2 years of randomization. Fifty-four of these 
patients (35%) had evidence of progression to >50% diameter 
stenosis in a vessel that did not have significant disease 
previously. This progression occurred in 16 of the 54 patients 
assigned to bypass urgery, 19 of the 52 allocated to angioplasty 
and 19 of the 53 assigned to medical therapy (p = NS). There 
was no relation between baseline or follow-up total or frac- 
tionated cholesterol levels and angiographic progression of 
disease. Baseline and follow-up total cholesterol levels were, 
respectively, 225 _+ 42 and 231 : 44 mg/dl for those with new 
lesions and 236 _+ 51 and 224 +_ 42 md/dl for those without new 
lesions (p = NS). 
At 2-year follow-up angiography, 47 patients assigned to 
medical therapy (89%) had a lesion 70% to 99% diameter 
stenosis, and 6 had an occluded artery' (11%). Thirty-three 
patients allocated to coronary angioplasty (63%) had a lesion 
<70% diameter stenosis; 15 (29%) had 7(1% to 99% diameter 
stenosis; and 4 (8%) had total occlusion of the left anterior 
descending coronary artery.'. Two patients assigned to bypass 
surgery (4%) had <70% diameter stenosis; 12 (22%) had 70c/; 
to 99% narrowing; and 40 (74%} had total occlusion of the left 
anterior descending coronary artery. Left internal mammary 
angiography disclosed no atherosclerosis and a patent anasto- 
mosis in all but one patient 2 years after bypass urgery. 
Baseline and follow-up global eft ventricular ejection frac- 
tion was 74 _+ 4% and 71 : 7~2: for those assigned to medical 
treatment, 77 _+ 6% and 73 = 7q- for those assigned to 
coronary angioplasty and 73 _+ 4% and 71 _+ 5% for those 
undergoing bypass urgery (p = NS among the groups and for 
baseline vs. follow-up studies). 
Discuss ion  
Autopsy and nonrandomized studies (3,4,17-19) emphasize 
the prognostic importance ofsevere proximal lesions of the left 
anterior descending coronary artery. More aggressive therapy 
is also recommended for patients with severe proximal eft 
anterior descending coronary artery disease because of the 
widespread assumption that prognosis is ultimately related to 
the amount of myocardium atrisk (20,21). 
Balloon angioplasty was introduced in the late 1970s as a 
less invasive form of limited coronary revascularization (22) 
and has since grown explosively. There were >300,000 angio- 
plasty procedures performed inthe United States in 1991, most 
of them single-vessel disease procedures, and, surprisingly, 
many were not performed in accordance with the established 
indications as outlined in some guidelines for the procedure 
(23). More recently, newer coronary angioplasty techniques 
have been compared with traditional balloon coronary angio- 
plasty in patients with proximal left anterior descending coro- 
nary artery stenoses (24). Despite a slight increase in the 
procedural success rate with atherectomy devices, there was 
still a significant proportion of in-hospital complications, and 
the restenosis rate during follow-up remained high. There are 
also few data assessing the relative efficacies of coronary 
angioplasty and surgical revascularizations, and this issue has 
been the focus of ongoing trials comparing these treatments in 
different subsets of patients with coronary artery disease 
(10-12,14,15). 
Nevertheless, despite the more guarded prognosis associ- 
ated with left anterior descending coronary artery involvement 
versus that for other coronary arteries, the outlook for all 
patients with single-vessel disease and preserved ventricular 
function is generally good, and it is not clear whether revascu- 
larization strategies result in better medium- or long-term 
outcomes than medical therapy alone. 
Study findings versus previous trials. We studied 214 
carefully selected patients with stable angina randomized to 
the three available therapies for single proximal left anterior 
descending coronary artery stenosis. All three interventions 
resulted in significant symptomatic relief, although the propor- 
tion of patients totally asymptomatic in the medical arm (32%) 
was significantly less than those in the coronary angioplasty 
(82%) and surgical (98%) groups. These results are in agree- 
ment with data published recently from the Angioplasty Com- 
pared to Medicine (ACME) trial (13), indicating that patients 
with single-vessel disease assigned to coronary angioplasty 
have more complete angina relief than do those assigned to 
medical therapy. However, all three therapies in this study 
resulted in the elimination of limiting angina, and the symp- 
tomatic benefit in the revascularization groups may not be 
clinically important. Mammary bypass urgery was associated 
with a greater event-free probability at an average follow-up of 
3 years than either coronary angioplasty or medical treatment. 
This benefit resulted from a very low surgical periprocedure 
complication rate, as well as the successful medium-term 
abolition of symptoms, which completely eliminated the need 
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for a repeat revascularization procedure. These results are 
comparable to other published series of patients with isolated 
left anterior descending coronary, artery disease treated with 
bypass urgery (25). Death and infarction rates were also low in 
patients assigned to medical therapy and angioplasty. How- 
ever, these treatments were associated with higher crossover 
rates to the other treatment arms because of the development 
of refractory angina during the follow-up period. 
The relatively benign course in the nonsurgical patients 
with proximal left anterior descending coronary artery narrow- 
ing observed in the present study may be related in part to the 
normal ventricular function in our patients. Klein et al. (4) 
evaluated a group of patients with left anterior descending 
coronary artery disease and normal ventricular function and 
reported a survival rate of 97% over an average follow-up 
period of 17 months. However, the presence of proximal eft 
anterior descending coronary artery stenosis was a better 
predictor of worse outcome than was altered anterior wall 
motion. In patients medically managed with normal eft ven- 
tricular function, Califf et al. (3) reported a survival rate of 
98% in those with isolated left anterior descending coronary, 
artery disease located after, and 90% with disease located 
before, the first septal perforator at 5 years of follow-up. 
The only other randomized comparison of coronary angio- 
plasty and bypass urgery for the treatment of patients with 
isolated proximal left anterior descending coronary artery 
stenosis was recently reported by Goy et al. (12). In a similar 
group of 134 patients with stable angina, they observed that 
86% of surgically revascularized patients and 43% of coronary 
angioplasty-treated patients were free of adverse vents after 
a median follow-up period of 2.5 years. These results parallel 
the significantly higher event-free probability of the patients 
who underwent bypass urgery in the present study (97% for 
bypass urgery vs. 76~+ for coronary angioplasty, p < 0.01). 
The lower proportion of events occurring during follow-up in 
the present report probably reflects a stricter definition of 
events and end points. However, in neither study was there a 
difference in cardiac death or myocardial infarction rates 
between coronary angioplasty and surgical revascularization. 
Also, Goy et al. (12) did not randomize a comparable group of 
patients to medical therapy alone. 
A comparison between balloon-expandable st nt implanta- 
tion and balloon angioplasty in patients with single-artery 
disease has been recently reported (26). During a 7-month 
follow-up period, there was an improvement in clinical and 
angiographic outcomes in patients receiving stents compared 
with those who underwent balloon angioplasty only, who were 
at a significantly higher risk of vascular complications and a 
longer hospital stay. All patients in the present study who were 
treated by angioplasty underwent standard balloon angio- 
plasty. Thus, it is unclear whether the use of newer interven- 
tional techniques such as stent implantation would alter the 
results presented here. 
We also observed significant progression of coronary ath- 
erosclerosis during the study. At 2-year follow-up angiography, 
35% of the patients had developed >50% stenosis in vessels 
previously free of significant narrowing at the baseline xami- 
nation. The atherosclerotic nvolvement of coronary arteries 
other than the left anterior descending coronary artery trans- 
forms the status of these patients from single-vessel to mul- 
tivessel disease, which could significantly influence the clinical 
course and treatment s rategies adopted. 
Conclusions and clinical implications. The use of mam- 
mary bypass urgery for the treatment of patients with stable 
angina and isolated, severe proximal stenosis of the left 
anterior descending coronary artery with normal ventricular 
function was associated with a higher event-free survival rate 
due to a lower reintervention rate than coronary angioplasty or 
medical treatment alone during an average follow-up period of 
3 years. However, there was significant progression of coronary 
atherosclerosis in nontreated vessels in all groups, and the 
three therapeutic strategies resulted in a similar success rate in 
terms of abolishing limiting angina and an equally low inci- 
dence of death or myocardial infarction during the 3-year 
follow-up period. Future cost-benefit analyses as well as longer 
follow-up studies are warranted. Ongoing efforts toward a 
meta-analysis of all available randomized ata may result in 
greater insight into the effects of these interventions on hard 
end points, such as mortality and infarction rates. 
We gratefully acknowledge Gary Gcrstenblith, MD, for critical analysis of the 
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